BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its audited financial results ...

On track to initiate Phase 1/2a clinical trial of GLIX1 for treatment of glioblastoma (GBM) by end of this month - - GLIX1 is positioned to potentially address unmet ...

Rakovina Therapeutics Inc. (TSX-V: RKV)(FSE: 7JO0), a biopharmaceutical company advancing innovative cancer therapies through ...

New research links gum disease to the development of breast cancer.

Breast cancer is one of the most common cancers in women around the world. Doctors have long known that many factors can affect the risk of developing this disease. These include genetics, lifestyle, ...

Lung cancer has long been seen as a disease mainly caused by smoking. However, doctors are now noticing a worrying pattern: ...

A surprising new study reveals that blocking a supposedly protective enzyme, Caspase-2, could actually backfire—raising the risk of chronic liver damage and cancer over time. Researchers found that ...

From air pollution to microplastics to natural radiation, these are the environmental factors that contribute to cancer risk ...

UCLA researchers have uncovered a hidden weakness in some of the deadliest cancers, revealing a potential new strategy for ...

Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?

A new blood test could change the outlook for one of the deadliest cancers—pancreatic cancer—by catching it much earlier than ...

New research indicates that psychosocial factors—which influence how a person perceives, interprets, and reacts to their ...